Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-09, Stock:PFE, The news for the past five days is as follows:
2021-02-02: NEWS1: Biden administration looks to directly ship vaccines to pharmacies.NEWS2: Pfizer Posts Strong Revenue and Big Expectations for 2021.NEWS3: Coronavirus Vaccine Maker Pfizer Posts a Mixed Q4.NEWS4: Pfizer Calls For $15 Billion In Covid Vaccine Sales; But Dives On Light Quarter.NEWS5: Pfizer’s Covid-19 vaccine is set to be one of the most lucrative drugs in the world.NEWS6: Pfizer Increased Vaccine Sales Estimate After AstraZeneca and J&J Stumbles.NEWS7: Pfizer Projects $15 Billion in 2021 Sales of Covid Vaccine.NEWS8: Doctor: We need to get vaccines 'in arms now to save lives'.NEWS9: Americans in priority groups can start getting vaccinated at some pharmacies starting Feb. 11.NEWS10: Peru regulators approve Pfizer vaccine against COVID-19 -filing.NEWS11: UPS CEO: We have delivered 36.5 million COVID-19 vaccines.NEWS12: Pfizer expects $15bn sales of Covid-19 vaccine.NEWS13: Mask mandate is an ‘imperative first step’ in fighting COVID-19: Doctor.NEWS14: Rep. Perlmutter on stimulus talks: ‘Covid is not waiting for anybody’.NEWS15: Pfizer Expects COVID-19 Vaccine To Bring $15B In Revenue This Year.NEWS16: Why Pfizer's Q4 Results Simply Don't Matter Very Much.NEWS17: Groundhog Day, But Nothing's the Same: Q4 for PFE, UPS.NEWS18: Pfizer Earnings: What Happened With PFE.NEWS19: Pfizer (PFE) Q4 Earnings Miss, Sales Beat, 2021 View Upbeat.NEWS20: Pfizer Lifts 2021 Guidance On Expectations Of $15B In Covid-19 Vaccine Sales.NEWS21: Pfizer Stock Inches Up Despite Light Fourth-Quarter Earnings.NEWS22: Pfizer Inc. to Host Earnings Call.NEWS23: Pfizer expects its COVID-19 vaccine to bring in about $15 billion in revenue this year.NEWS24: The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment.NEWS25: Pfizer (PFE) Misses Q4 Earnings Estimates.NEWS26: Doctor on coronavirus: 'We're in an arms race now'.NEWS27: Pfizer Just Reported Earnings. Here’s the One Number to Notice..NEWS28: Pfizer: Q4 Earnings Insights.NEWS29: Pfizer stock slips after profit misses expectations, while revenue beats.NEWS30: Pfizer sees about $15 billion in 2021 sales from COVID-19 vaccine.NEWS31: What's the Upside for Novavax Stock?.NEWS32: Pfizer sees $15 billion in 2021 sales from COVID-19 vaccine.NEWS33: PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS.NEWS34: Will Pfizer's Latest Bad News Wipe Out a Big Chunk of Its COVID Vaccine Profits?.NEWS35: There's No Reason to Give Up on Pfizer.NEWS36: Pfizer, UPS, Exxon, Alibaba - Tuesday's Premarket Movers.NEWS37: Pfizer Misses Q4 Earnings Forecast, Sees COVID Vaccine Boost To 2021 Profits.NEWS38: Pfizer expects $15bn in Covid vaccine revenue this year.
2021-02-03: NEWS1: Vaxart Stock Crashes After Oral Covid Vaccine Fails To Produce Antibodies.NEWS2: On-demand-dental company Medbar pivots model to become COVID-19 medical service.NEWS3: Pfizer Is Ready, Even For COVID-19 Variants.NEWS4: Doctor on COVID-19 progress: 'We’re definitely not out of the woods yet'.NEWS5: Coronavirus update: US hits 1M shots per day average as scientists eye second generation COVID-19 vaccines.NEWS6: 10 Biggest Companies That Were Dropped From the Dow Jones Industrial Average (DJIA).NEWS7: This is the straightforward explanation why more COVID-19 vaccines can’t be quickly produced.NEWS8: Switzerland Declines To Approve AstraZeneca COVID-19 Vaccine - Financial Times.NEWS9: Lifted by a Short Squeeze, Vaxart Stock Sinks on Lackluster Vaccine News.NEWS10: U.S. COVID cases continue to fall, even with one-day death rate still above 3,000.NEWS11: P/E Ratio Insights for Pfizer.NEWS12: Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more.NEWS13: The U.S. Scrambles to Overcome Its Vaccine Shortage.NEWS14: GlaxoSmithKline Will Develop Next-Generation Vaccine With Biotech CureVac.NEWS15: Serbians free to pick their vaccine amid plentiful supply.NEWS16: Imcyse Enters into Research Collaboration and License Agreement for its Imotope(TM) Technology with Pfizer in Rheumatoid Arthritis.NEWS17: IBD/TIPP Poll Shows Why J&J's Covid Shot Might Face An Uphill Battle.NEWS18: Is It Too Late to Buy Pfizer Stock?.NEWS19: Amazon Had a $126 Billion Quarter, and Two More Numbers to Know.NEWS20: Pfizer (PFE) Q4 2020 Earnings Call Transcript.NEWS21: Australia places no upper age limit on Pfizer coronavirus vaccine.NEWS22: New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine.
2021-02-04: NEWS1: Watch Replay–A Golden Era of Medicine: Mira Life Science Ventures CEO in Fireside Chat.NEWS2: J&J submits application for its COVID-19 shot to the FDA.NEWS3: Restrictions Ease in U.S.; No Lockdown for France: Virus Update.NEWS4: U.S. coronavirus cases slowing is an ‘opportunity:’ Doctor.NEWS5: Doctor: 'It’s not about when I get vaccinated, it’s when we get vaccinated'.NEWS6: Peru inks deal with Pfizer for 20 million doses of coronavirus vaccine.NEWS7: Merrick Garland Pledges to Sell Stocks After Confirmation as Attorney General.NEWS8: U.S. death toll tops 450,000 but hospitalizations decline for a 23rd straight day.NEWS9: Israel says vaccine has almost halved COVID cases among over-60s.NEWS10: Early backers of vaccine maker BioNTech in $719 million payday.NEWS11: Novavax Surges On Highly Effective Covid Shot; Is NVAX Stock A Buy?.NEWS12: What Biden's health care priorities should be, according to experts.NEWS13: Here's How Novavax's Vaccine Stacks Up Against Moderna's and Pfizer's.NEWS14: UK To Test Combining Pfizer And AstraZeneca Vaccines In Two-Shot Regimen - Reuters.NEWS15: Here's Why Pfizer's a Great Stock to Buy and Hold Now.NEWS16: Malaysia sets Feb 2022 target to complete COVID-19 vaccine rollout.NEWS17: UK says 4,000 variants of virus that causes COVID-19 around the world.NEWS18: Broker Revenue Forecasts For Pfizer Inc. (NYSE:PFE) Are Surging Higher.NEWS19: U.K. to test mixing and matching of COVID-19 vaccines.NEWS20: A straightforward explanation why more COVID-19 vaccines can’t be produced with help from ‘dozens’ of companies.NEWS21: Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen.
2021-02-05: NEWS1: J&J, Novavax Ask FDA To Authorize Covid Vaccines — Shares Surge Higher.NEWS2: Novavax Hits Record High After Seeking Covid Vaccine OK; Is It A Buy?.NEWS3: COVAX bottlenecks need to be urgently addressed, U.N. agency says.NEWS4: Pharma ETFs in Focus Post Q4 Earnings.NEWS5: Top Stock Reports for Alphabet, Pfizer & Uber.NEWS6: J&J’s COVID-19 vaccine candidate sparks hopes for faster recovery, just as daily deaths spike above 5,000 in the U.S..NEWS7: J&J (JNJ) Seeks Emergency Approval for Coronavirus Vaccine.NEWS8: Amazon Stock Will Be Fine Without Jeff Bezos.NEWS9: Pharma Stock Roundup: PFE, MRK Q4 Earnings, AZN, JNJ Coronavirus Vaccine Updates.NEWS10: These early BioNTech investors just saw their faith rewarded with a $719 million payday.NEWS11: Coronavirus update: J&J applies for vaccine emergency use; FDA to address variants.NEWS12: FDA schedules advisory committee for J&J's COVID-19 vaccine candidate for Feb. 26.NEWS13: Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027.NEWS14: Seven million Italians could be fully vaccinated by end-March - COVID commissioner.NEWS15: Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial - Reuters.NEWS16: INSIGHT-Countdown to 'catastrophe:' Inside Europe's fight for COVID shots.NEWS17: 3 Top Stocks You Can Buy and Hold for the Next Decade.NEWS18: Johnson & Johnson Asks FDA To Authorize Covid Vaccine; Shares Pop.NEWS19: Sanofi to expand cost-savings push as earnings beat expectations.
2021-02-08: NEWS1: If we roll out the coronavirus vaccine 'in a stepwise fashion, I think that we can be successful': Doctor.NEWS2: Vaccines Are Still Protecting Against the Coronavirus Variants (for Now).NEWS3: EU finalises second deal with Pfizer for 300 mln vaccine doses.NEWS4: Coronavirus pandemic: 'Every additional vaccine is a game changer'.NEWS5: AstraZeneca COVID-19 vaccine concerns shrugged off by U.K. and Australia.NEWS6: Coronavirus update: Variant concerns rising globally as spread grows in US.NEWS7: How the ‘grandma phenomenon’ is influencing when people get the COVID-19 vaccine.NEWS8: U.S. COVID case tally tops 27 million, while South Africa abandons AstraZeneca vaccine.NEWS9: Why Johnson & Johnson's Vaccine Data Is Actually Great News.NEWS10: How ‘meme stocks’ and recent retail investor activity are impacting markets.NEWS11: UK PM Johnson says: We're confident our vaccines prevent deaths.NEWS12: The Zacks Analyst Blog Highlights: Google, Pfizer, Uber, Cisco Systems and ConocoPhillips.

Answer: Rise